CLIC6’s role in cancer: from broad analysis to breast cancer validation
In conclusion, CLIC6 can serve as a key biomarker for various cancers, and its expression level is related to the tumor immune microenvironment and the outcomes in selected cancers; further validation is warranted. Our research on CLIC6 in BRCA has revealed new potential for tumor treatment strategies targeting this marker.
Authors
- Chenming Guo (ORCID: https://orcid.org/0000-0002-4531-8958)
- Haotian Ma (ORCID: https://orcid.org/0000-0001-7257-7392)
- Dilimulati Ismtula
- Juan Hou (ORCID: https://orcid.org/0000-0003-3869-2658)
- Jiaqi Li (ORCID: https://orcid.org/0000-0001-6076-4350)
- Jindong Wang (ORCID: https://orcid.org/0000-0002-4833-0880)
- Yiyang Wang (ORCID: https://orcid.org/0000-0002-0318-6715)
- Yongxiang Li (ORCID: https://orcid.org/0009-0001-6230-9594)
Institutions
- Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-09
- DOI
- https://doi.org/10.3389/fonc.2025.1667589
- Citations
- 6
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 4.84